DEC cells were extensively tested in preclinical studies where long-term safety and engraftment correlated with dystrophin expression and functional improvements in the DMD-affected organs including cardiac, respiratory and skeletal muscles. The gene discussed is DMD; the disease is Duchenne muscular dystrophy.